SCHEDULE 13G/A//SEC Filing
CASI Pharmaceuticals, Inc. SCHEDULE 13G/A
Accession 0001104659-25-076826
CIK 0001932516other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:05 PM ET
Size
13.7 KB
Accession
0001104659-25-076826
Documents
Issuer
Foresite Capital Fund VI LP
CIK 0001932516
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001932516
Filing Metadata
- Form type
- SCHEDULE 13G/A
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:05 PM ET
- Size
- 13.7 KB